Literature DB >> 31511327

A modular PROTAC design for target destruction using a degradation signal based on a single amino acid.

Karthigayan Shanmugasundaram1, Peng Shao2, Han Chen3, Bismarck Campos4, Stanton F McHardy4, Tuoping Luo2,3, Hai Rao5.   

Abstract

Proteolysis targeting chimeras (PROTACs) are bivalent molecules that bring a cellular protein to a ubiquitin ligase E3 for ubiquitination and subsequent degradation. Although PROTAC has emerged as a promising therapeutic means for cancers as it rewires the ubiquitin pathway to destroy key cancer regulators, the degradation signals/pathways for PROTACs remain underdeveloped. Here we append single amino acids, the simplest degradation signal, to a ligand specific for estrogen-related receptor α (ERRα) and demonstrate their utility in ERRα knockdown via the N-end rule pathway and also their efficiency in the growth inhibition of breast cancer cells. The modular design described offers unique advantages including smaller molecular size with shortest degradation sequences and degradation speed modulation with different amino acids. Our study expands the repertoire of limited ubiquitin pathways currently available for PROTACs and could be easily adapted for broad use in targeted protein degradation.
© 2019 Shanmugasundaram et al.

Entities:  

Keywords:  N-end rule; PROTAC; drug design; drug development; drug therapy; proteasome; protein degradation; protein targeting; protein turnover; proteolysis; ubiquitin

Mesh:

Substances:

Year:  2019        PMID: 31511327      PMCID: PMC6791330          DOI: 10.1074/jbc.AC119.010790

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Authors:  K M Sakamoto; K B Kim; A Kumagai; F Mercurio; C M Crews; R J Deshaies
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 2.  The Ubiquitin System, Autophagy, and Regulated Protein Degradation.

Authors:  Alexander Varshavsky
Journal:  Annu Rev Biochem       Date:  2017-06-20       Impact factor: 23.643

3.  Recent progress in ubiquitin and ubiquitin-like protein (Ubl) signaling.

Authors:  Ronggui Hu; Mark Hochstrasser
Journal:  Cell Res       Date:  2016-04       Impact factor: 25.617

4.  In vivo half-life of a protein is a function of its amino-terminal residue.

Authors:  A Bachmair; D Finley; A Varshavsky
Journal:  Science       Date:  1986-10-10       Impact factor: 47.728

Review 5.  The N-end rule pathway.

Authors:  Takafumi Tasaki; Shashikanth M Sriram; Kyong Soo Park; Yong Tae Kwon
Journal:  Annu Rev Biochem       Date:  2012-04-10       Impact factor: 23.643

Review 6.  Targeted protein degradation: elements of PROTAC design.

Authors:  Stacey-Lynn Paiva; Craig M Crews
Journal:  Curr Opin Chem Biol       Date:  2019-04-17       Impact factor: 8.822

7.  Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.

Authors:  Carl C Ward; Jordan I Kleinman; Scott M Brittain; Patrick S Lee; Clive Yik Sham Chung; Kenneth Kim; Yana Petri; Jason R Thomas; John A Tallarico; Jeffrey M McKenna; Markus Schirle; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

Review 8.  Ubiquitin ligases in oncogenic transformation and cancer therapy.

Authors:  Daniela Senft; Jianfei Qi; Ze'ev A Ronai
Journal:  Nat Rev Cancer       Date:  2017-12-15       Impact factor: 60.716

Review 9.  ERRα as a Bridge Between Transcription and Function: Role in Liver Metabolism and Disease.

Authors:  Hui Xia; Catherine R Dufour; Vincent Giguère
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-05       Impact factor: 5.555

10.  Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4.

Authors:  Yuan Xiao Zhu; Chang-Xin Shi; Laura A Bruins; Xuewei Wang; Daniel L Riggs; Brooke Porter; Jonathan M Ahmann; Cecilia Bonolo de Campos; Esteban Braggio; P Leif Bergsagel; A Keith Stewart
Journal:  Blood Cancer J       Date:  2019-02-11       Impact factor: 11.037

View more
  2 in total

1.  The N-terminal domain of the non-receptor tyrosine kinase ABL confers protein instability and suppresses tumorigenesis.

Authors:  Zhengwei Yan; Karthigayan Shanmugasundaram; Dongwen Ma; Jiayu Luo; Shiwen Luo; Hai Rao
Journal:  J Biol Chem       Date:  2020-05-21       Impact factor: 5.157

2.  Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1.

Authors:  So Ra Choi; Hee Myeong Wang; Min Hyeon Shin; Hyun-Suk Lim
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.